Innovation

Australian innovation pilot aims to reduce cost of vaccination in developing world

GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.

Our Community

Victoria Police - Trek of a lifetime

We have been a long-standing supporter of the Victoria Police Kokoda Project, supporting the initiative since it began in 2007.

How we do business

Crowd sourcing new treatments for malaria

New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.

Access to healthcare

Increasing medicine access across the world's poorest nations

GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

How we do business

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Our Community

A comic book on vaccines

Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.